Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or North Carolina for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to North Carolina only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. North Carolina (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Igor Westra (NPI 1679543870)

Field	Value
Entity Type	Individual
Organization	Igor Westra
Address	1801 New Hanover Medical Park Dr
City	Wilmington
State	NC
ZIP	28403
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	January 23, 2006

Payer Source	Total Paid
Medicare	$2.6M
Medicaid	$0

Key Findings

This provider is a retina-focused ophthalmology practice whose Medicare revenue is dominated by intravitreal anti-VEGF medications and associated injection services. The top revenue drivers are medication codes J0178, J2777, and J2778 (all intravitreal injections), and the separate injection procedure 67028 also appears in the top codes, indicating day-of-care procedural throughput centered on retinal injections rather than broad primary-care E/M services.

Revenue is highly concentrated in a small set of drug codes: the precomputed top 3 Medicare codes by revenue account for 87.3% of this provider's total Medicare revenue, with J0178 at $1.3M (48.6%), J2777 at $616K (23.8%), and J2778 at $387.2K (14.9%). This concentration shows that most Medicare dollars flow from anti-VEGF therapy rather than diagnostic or general ophthalmology visits.

Payer mix is effectively single-payer at the claim level: total Medicare revenue is $2.6M while there is no Medicaid billing on file. The absence of Medicaid billing means the provider’s revenue and risk profile is concentrated in Medicare patients and Medicare reimbursement policy changes could materially affect volume and revenue.

On national competitive standing for the medication codes, this provider ranks in typical to moderately above-typical ranges: J0178 ranks #608 of 3204 providers (81th percentile; typical, unremarkable volume for this code), J2777 ranks #488 of 2039 providers (76th percentile; typical, unremarkable volume for this code), and J2778 ranks #201 of 1208 providers (83th percentile; typical, unremarkable volume for this code). These percentiles indicate the provider is a solid regional participant in anti-VEGF therapy but not a dominant national center for these injectable drugs.

Ancillary retinal imaging and diagnostics are a standout service line for this provider: 92250 (fundus photography) is an extreme outlier (ranks #206 of 25087 nationally, 99th percentile), and 92228 (remote retinal image interpretation) ranks #2 of 126 providers nationally (99th percentile, extreme outlier). Additional imaging codes such as 92014 (comprehensive established exam) and 92134 (retinal imaging with interpretation) are also notably above typical national volume (95th and 94th percentiles, respectively), suggesting a high-capacity imaging workflow and a meaningful revenue stream from diagnostic services.

Clinical office E/M services generate comparatively little Medicare revenue relative to injections and imaging: for example, 99213 accounts for $6.6K (0.3%) and 99214 accounts for $2.3K (0.1%) of Medicare revenue, while 92014—an ophthalmology-established comprehensive exam—contributes $84.4K (3.3%) but is an outlier in volume. This pattern indicates the practice emphasizes procedure- and imaging-based revenue over traditional nonprocedural E/M billing.

Operationally, the provider appears established with long tenure: the NPI was enumerated on 2006-01-23 (~20 years ago) and the practice has accumulated $2.6M in Medicare revenue over its lifetime. The combination of long-standing billing activity and concentrated procedural/injection volume is consistent with a specialty retina practice that has built a stable Medicare patient base.

The mix of notable statistical outliers and otherwise typical rankings points to a focused business model: extreme outlier status on 92250 and 92228 indicates unusually high retinal imaging and remote-interpretation activity, while the drug-injection ranks are typical for high-volume retina practitioners (e.g., 67028 at $142.8K, 5.5% of Medicare revenue, ranks #565 of 4255, 87th percentile; typical, unremarkable volume). For payers and analysts, this profile signals concentration risk around anti-VEGF drug reimbursement and a differentiated ancillary imaging capability that could be a leverage point in network negotiations or utilization reviews.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,830	$690	$1.3M
J2777	Injection, faricimab‑svoa, 0.1 mg	21,240	$30	$616K
J2778	Injection, ranibizumab, 0.1 mg	2,150	$180	$387.2K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,740	$80	$142.8K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	980	$90	$84.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,450	$30	$43.5K
92250	Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,…	1,080	$30	$28K
92004	The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits.	70	$110	$7.1K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	110	$60	$6.6K
92228	The patient undergoes retinal imaging on one or both eyes in a location other than the reviewing provider’s location. The provider interprets the images remotely and prepares a report. The imaging…	410	$10	$4.9K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. North Carolina Distribution

Igor Westra — 3 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — North Carolina

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	27	100	950	$690	$881K
J2777	26	70	12,990	$30	$503.7K
J2778	5	50	620	$180	$202.2K
67028	20	120	780	$90	$80K
92014	31	880	110	$80	$17.7K
99214	15,645	18,060	110	$80	$15.1K
92134	44	790	70	$30	$7.5K
99213	5,632	16,320	70	$50	$7.1K
99204	5,972	8,430	30	$110	$4.8K
92004	126	620	30	$90	$4.6K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with Igor Westra, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Henry Holt	NC	Ophthalmology Physician	$2.7M	$0
John Deans	NC	Ophthalmology Physician	$2.4M	$0

Nearby Providers

Other providers in the same ZIP code as Igor Westra, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Wilmington Medical Supply Inc	NC	Durable Medical Equipment & Medical Supplies	$0	$47.8M
A2z Home Medical Supplies, Inc	NC	Durable Medical Equipment & Medical Supplies	$0	$47.4M
Maxim Healthcare Services, Inc.	NC	Home Health Agency	$0	$33.8M
Bayada Home Health Care, Inc.	NC	Home Health Agency	$0	$28.3M
Physician Alliance For Mental Health, LLC	NC	Community/Behavioral Health Agency	$0	$28M
Easter Seals Ucp North Carolina & Virgiinia, Inc.	NC	Community/Behavioral Health Agency	$0	$19.2M
Bayada Home Health Care, Inc.	NC	Developmental Disabilities Clinic/Center	$0	$18M
Therapy Works Of Wilmington	NC	Speech-Language Pathologist	$0	$12.2M
Coastline Therapy Group, LLC	NC	Speech-Language Pathologist	$0	$11.8M
Pd Of Wilmington Inc	NC	In Home Supportive Care Agency	$0	$11.4M

Igor Westra — Billing Profile & Reimbursement Data

Sign up for Igor Westra — Billing Profile & Reimbursement Data policy alerts

Igor Westra — Billing Profile & Reimbursement Data

Sign up for Igor Westra — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References